Variant report

Variant	nsv10139
Chromosome Location	chr1:46352461-46377771
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr1:46358025-46358337	HepG2	liver:	n/a	n/a
2	BRCA1	chr1:46357793-46358390	Hela-S3	cervix:	n/a	n/a
3	CEBPB	chr1:46355275-46355537	A549	lung:	n/a	chr1:46355333-46355344
4	CEBPB	chr1:46353141-46353499	HepG2	liver:	n/a	chr1:46353457-46353468 chr1:46353457-46353468 chr1:46353457-46353470 chr1:46353457-46353470 chr1:46353457-46353470
5	CEBPB	chr1:46355276-46355476	HepG2	liver:	n/a	chr1:46355333-46355344
6	CEBPB	chr1:46358033-46358416	Hela-S3	cervix:	n/a	n/a
7	CEBPB	chr1:46356545-46356641	K562	blood:	n/a	chr1:46356594-46356605 chr1:46356610-46356621
8	CEBPB	chr1:46355274-46355471	IMR90	lung:	n/a	chr1:46355333-46355344
9	CEBPB	chr1:46356579-46356734	HepG2	liver:	n/a	chr1:46356594-46356605 chr1:46356610-46356621
10	CEBPB	chr1:46353207-46353444	HepG2	liver:	n/a	n/a
11	CEBPB	chr1:46355249-46355478	K562	blood:	n/a	chr1:46355333-46355344
12	CEBPB	chr1:46372369-46372562	K562	blood:	n/a	n/a
13	CEBPB	chr1:46369520-46369776	HepG2	liver:	n/a	chr1:46369612-46369623
14	CTCF	chr1:46365144-46365169	MCF-7	breast:	n/a	n/a
15	CTCF	chr1:46365100-46365250	K562	blood:	n/a	n/a
16	CTCF	chr1:46365097-46365199	MCF-7	breast:	n/a	n/a
17	CTCF	chr1:46365020-46365170	HMF	breast:	n/a	n/a
18	CTCF	chr1:46365020-46365170	HepG2	liver:	n/a	n/a
19	CTCF	chr1:46365148-46365155	HUVEC	blood vessel:	n/a	n/a
20	CTCF	chr1:46364960-46365110	RPTEC	kidney:	n/a	n/a
21	CTCF	chr1:46364980-46365130	GM12873	blood:	n/a	n/a
22	CTCF	chr1:46365100-46365250	RPTEC	kidney:	n/a	n/a
23	CTCF	chr1:46365040-46365190	HMF	breast:	n/a	n/a
24	CTCF	chr1:46365132-46365188	Hela-S3	cervix:	n/a	n/a
25	CTCF	chr1:46368720-46368870	GM12873	blood:	n/a	n/a
26	CTCF	chr1:46354950-46354988	Fibrobl	skin:	n/a	n/a
27	CTCF	chr1:46354990-46354993	Fibrobl	skin:	n/a	n/a
28	CTCF	chr1:46365120-46365270	HCT-116	colon:	n/a	n/a
29	CTCF	chr1:46365137-46365142	HUVEC	blood vessel:	n/a	n/a
30	CTCF	chr1:46365112-46365208	K562	blood:	n/a	n/a
31	CTCF	chr1:46365040-46365190	HEK293	kidney:	n/a	n/a
32	CTCF	chr1:46365162-46365193	K562	blood:	n/a	n/a
33	CTCF	chr1:46365120-46365270	MCF-7	breast:	n/a	n/a
34	CTCF	chr1:46365125-46365131	Hela-S3	cervix:	n/a	n/a
35	E2F4	chr1:46365305-46365311	MCF10A-Er-Src	breast:	n/a	n/a
36	E2F4	chr1:46358153-46358481	MCF10A-Er-Src	breast:	n/a	n/a
37	ELF1	chr1:46357531-46357787	K562	blood:	n/a	chr1:46357626-46357639
38	EP300	chr1:46358071-46358525	HepG2	liver:	n/a	n/a
39	EP300	chr1:46357944-46358621	SK-N-SH	brain:	n/a	n/a
40	EP300	chr1:46357780-46358403	Hela-S3	cervix:	n/a	n/a
41	EP300	chr1:46357841-46358580	ECC-1	luminal epithelium:	n/a	n/a
42	EP300	chr1:46358158-46358390	SK-N-SH_RA	brain:	n/a	n/a
43	EP300	chr1:46353169-46353589	HepG2	liver:	n/a	chr1:46353455-46353469
44	FOS	chr1:46357955-46358503	HUVEC	blood vessel:	n/a	chr1:46358208-46358219 chr1:46358472-46358481
45	FOS	chr1:46361079-46361461	MCF10A-Er-Src	breast:	n/a	chr1:46361266-46361277 chr1:46361264-46361273
46	FOS	chr1:46358026-46358523	MCF10A-Er-Src	breast:	n/a	chr1:46358208-46358219 chr1:46358472-46358481
47	FOS	chr1:46361079-46361416	MCF10A-Er-Src	breast:	n/a	chr1:46361266-46361277 chr1:46361264-46361273
48	FOS	chr1:46361144-46361385	MCF10A-Er-Src	breast:	n/a	chr1:46361266-46361277 chr1:46361264-46361273
49	FOS	chr1:46358020-46358456	MCF10A-Er-Src	breast:	n/a	chr1:46358208-46358219
50	FOS	chr1:46361067-46361409	MCF10A-Er-Src	breast:	n/a	chr1:46361266-46361277 chr1:46361264-46361273

No.	Distal block	Cell Line	Cell type
1	chr1:46311352..46313846-chr1:46355275..46357260,2	K562	blood:
2	chr1:46357830..46359619-chr1:46362753..46364302,2	K562	blood:
3	chr1:46357830..46359619-chr1:46362753..46364302,2	K562	blood:
4	chr1:46334716..46337442-chr1:46355883..46358850,3	K562	blood:
5	chr1:46349975..46352089-chr1:46365133..46367847,2	K562	blood:
6	chr1:46360342..46362505-chr1:46373607..46378298,4	K562	blood:
7	chr1:46048410..46052093-chr1:46358186..46360944,3	K562	blood:
8	chr1:46346412..46348926-chr1:46358537..46360878,2	K562	blood:
9	chr1:46370026..46372652-chr1:46374945..46376718,2	K562	blood:
10	chr1:46152030..46155728-chr1:46349059..46353962,4	K562	blood:
11	chr1:46358179..46359900-chr1:46645424..46647208,2	MCF-7	breast:
12	chr1:46370026..46372652-chr1:46374945..46376718,2	K562	blood:
13	chr1:46329534..46331128-chr1:46362467..46364128,2	K562	blood:
14	chr1:46345992..46348458-chr1:46350883..46353705,2	K562	blood:
15	chr1:46360342..46362505-chr1:46373607..46378298,4	K562	blood:
16	chr1:46299700..46301655-chr1:46355026..46357168,2	MCF-7	breast:

Variant related genes	Relation type
MAST2	TF binding region
ENSG00000132780	chromatin interactions
ENSG00000159596	chromatin interactions
ENSG00000232467	chromatin interactions
ENSG00000159592	chromatin interactions

Extended variants
information (count: 887 )
Associated
traits (count: 96 )

Variant overlapped rSNPs/rCNVs (count:887 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10789479	chr1:46352500-46352501	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs563428543	chr1:46352502-46352503	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs530881395	chr1:46352513-46352514	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs544810367	chr1:46352547-46352548	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs150044234	chr1:46352564-46352565	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs386630880	chr1:46352565-46352566	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs376017433	chr1:46352567-46352568	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs549089207	chr1:46352571-46352572	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs181774713	chr1:46352579-46352580	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs555134557	chr1:46352585-46352586	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs7553924	chr1:46352624-46352625	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
12	rs546969674	chr1:46352631-46352632	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs143313137	chr1:46352643-46352644	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs113002414	chr1:46352650-46352651	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs557820142	chr1:46352657-46352658	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs113939222	chr1:46352769-46352770	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs576121745	chr1:46352785-46352786	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs61300244	chr1:46352798-46352799	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs184599451	chr1:46352812-46352813	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs189360076	chr1:46352841-46352842	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs541258666	chr1:46352930-46352931	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs552972591	chr1:46352940-46352941	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs534904382	chr1:46352990-46352991	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs377083722	chr1:46353003-46353004	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs544993004	chr1:46353043-46353044	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs374133704	chr1:46353062-46353063	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs563317449	chr1:46353160-46353161	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs532312720	chr1:46353186-46353187	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs530817777	chr1:46353221-46353222	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs546032803	chr1:46353257-46353258	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs12141934	chr1:46353332-46353333	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
32	rs35347359	chr1:46353345-46353346	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs79239157	chr1:46353388-46353389	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs374910612	chr1:46353419-46353420	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs181936692	chr1:46353490-46353491	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs185159247	chr1:46353574-46353575	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs571830620	chr1:46353588-46353589	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs4641257	chr1:46353589-46353590	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
39	rs547967648	chr1:46353652-46353653	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs567843913	chr1:46353656-46353657	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs569622322	chr1:46353659-46353660	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs138916093	chr1:46353680-46353681	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs537051047	chr1:46353688-46353689	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs555490132	chr1:46353719-46353720	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs369950608	chr1:46353749-46353750	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs191001989	chr1:46353752-46353753	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs181078727	chr1:46353756-46353757	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs553100112	chr1:46353780-46353781	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs577785226	chr1:46353803-46353804	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs186435222	chr1:46353833-46353834	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:96)

Disease	PMID	Source
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioblastoma multiforme	21080181	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	17603634	CNVD
Soft tissue tumor	16732325	CNVD
Papillary thyroid carcinoma	21436994	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Colorectal cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Coronary Disease	20032323	CNVD
Prostate cancer	21965145	CNVD
Stargardt''s disease	17277736	CNVD
Neuroblastoma	17897457	CNVD
Uveal melanoma	21693616	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-syndromic sensorineural hearing loss	22290220	CNVD
Liposarcoma	21253554	CNVD
Breast cancer	21264507	CNVD
Acute myeloid leukemia	16864856	CNVD
Astrocytoma	17387387	CNVD
Cancer	21499728	CNVD
Glioblastoma multiforme	17387387	CNVD
Oligodendroglial tumors	17285580	CNVD
Neuroblastoma	17535989	CNVD
Pheochromocytoma	17535989	CNVD
Prostate cancer	16705090	CNVD
Astrocytoma	17934521	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Neuroblastoma	17533364	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Chronic myeloid leukemia	21384125	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Non-small cell lung cancer	21385341	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Chordoma	21602918	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Multiple myeloma	16461302	CNVD
Melanoma	17363583	CNVD
Cancer	21129771	CNVD
Autosomal dominant nocturnal frontal lobe epilepsy	18472482	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-small cell lung cancer	20864512	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Thrombocytopenia-absent radius syndrome	21933853	CNVD
Psychiatric disorder	22848183	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Hepatocellular carcinoma	16750200	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	20409316	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	17393978	CNVD
Cervical cancer	21062161	CNVD
Cancer	21183584	CNVD
Uveal melanoma	20484589	CNVD
Ovarian cancer	22174824	CNVD
Muscle-eye-brain disease	21572526	CNVD
Breast cancer	21785460	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	20680643	CNVD
Colorectal cancer	19287155	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21364760	CNVD
Ovarian cancer	17875760	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:366 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:46330200-46353200	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
2	chr1:46330200-46357600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
3	chr1:46332200-46357400	Weak transcription	Cortex derived primary cultured neurospheres	brain
4	chr1:46333800-46357400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
5	chr1:46336600-46356800	Weak transcription	Small Intestine	intestine
6	chr1:46336600-46357600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
7	chr1:46337800-46356000	Weak transcription	Sigmoid Colon	Sigmoid Colon
8	chr1:46338000-46357400	Weak transcription	Hela-S3	cervix
9	chr1:46338400-46353000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
10	chr1:46338400-46357600	Weak transcription	Fetal Intestine Large	intestine
11	chr1:46339200-46355000	Weak transcription	Fetal Intestine Small	intestine
12	chr1:46342200-46357000	Weak transcription	HUVEC	blood vessel
13	chr1:46342200-46391200	Weak transcription	Primary hematopoietic stem cells short term culture	blood
14	chr1:46346400-46357000	Weak transcription	Left Ventricle	heart
15	chr1:46347200-46357400	Weak transcription	Muscle Satellite Cultured Cells	--
16	chr1:46347400-46353000	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
17	chr1:46347400-46357200	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
18	chr1:46347400-46357400	Weak transcription	NH-A	brain
19	chr1:46347400-46357400	Weak transcription	NHDF-Ad	bronchial
20	chr1:46347400-46378400	Weak transcription	Brain Germinal Matrix	brain
21	chr1:46348600-46352800	Weak transcription	HSMMtube	muscle
22	chr1:46349600-46369000	Weak transcription	Dnd41	blood
23	chr1:46349800-46352800	Weak transcription	Osteobl	bone
24	chr1:46349800-46353200	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
25	chr1:46349800-46353800	Enhancers	Rectal Mucosa Donor 31	rectum
26	chr1:46349800-46357600	Weak transcription	Rectal Smooth Muscle	rectum
27	chr1:46350000-46357400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
28	chr1:46350600-46354600	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
29	chr1:46350600-46357600	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
30	chr1:46350800-46378800	Weak transcription	K562	blood
31	chr1:46351000-46352800	Weak transcription	A549	lung
32	chr1:46351000-46356800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
33	chr1:46351000-46357000	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
34	chr1:46351200-46353000	Weak transcription	HSMM	muscle
35	chr1:46351400-46352600	Enhancers	Duodenum Mucosa	Duodenum
36	chr1:46351600-46355600	Weak transcription	Stomach Mucosa	stomach
37	chr1:46352000-46352800	Enhancers	Skeletal Muscle Female	skeletal muscle
38	chr1:46352200-46353600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
39	chr1:46352200-46353800	Enhancers	HepG2	liver
40	chr1:46352400-46353000	Enhancers	Fetal Muscle Leg	muscle
41	chr1:46352400-46353400	Enhancers	Skeletal Muscle Male	skeletal muscle
42	chr1:46352400-46353800	Enhancers	Psoas Muscle	Psoas
43	chr1:46352400-46357600	Weak transcription	Rectal Mucosa Donor 29	rectum
44	chr1:46352600-46353400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
45	chr1:46352600-46357600	Weak transcription	Duodenum Mucosa	Duodenum
46	chr1:46352800-46353000	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
47	chr1:46352800-46353600	Enhancers	Osteobl	bone
48	chr1:46352800-46353800	Enhancers	A549	lung
49	chr1:46352800-46353800	Enhancers	HSMMtube	muscle
50	chr1:46353000-46353200	Enhancers	Skeletal Muscle Female	skeletal muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links